DailyStocks Stock Article Search

https://seekingalpha.com/article/4669347-qiagen-n-v-qgen-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Feb 11, 2024 - Qiagen N.V. (NYSE:NYSE:QGEN) Q4 2023 Earnings Conference Call February 7, 2024 9:00 AM ETCompany ParticipantsJohn Gilardi - VP, Corporate Communications... 0

https://www.zacks.com/stock/news/2203003/here-s-why-you-should-retain-qiagen-qgen-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2203003 Dec 28, 2023 - Investors remain optimistic about QIAGEN (QGEN), backed by strategic alliances and potential in the Molecular Diagnostics arena. 0

https://www.zacks.com/stock/news/2250721/qiagen-qgen-boosts-cancer-research-suite-with-new-launches?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250721 Apr 04, 2024 - QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024. 0

https://www.zacks.com/stock/news/2197534/qiagen-s-qgen-strategic-alliances-aid-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2197534 Dec 13, 2023 - QIAGEN (QGEN) aims to expand the NGS platform by rapidly scaling up the new Enterprise Genomics Services. 0

https://www.zacks.com/stock/news/2207546/qiagen-qgen-gains-from-new-alliances-amid-fx-headwind?cid=CS-ZC-FT-analyst_blog|zer_report_update-2207546 Jan 09, 2024 - QIAGEN (QGEN) is progressing well with its testing menu expansion strategy, which is driving the company's growth. 0

https://www.zacks.com/stock/news/2209391/qiagen-qgen-wins-fda-clearance-for-neumodx-ct-ng-assay?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2209391 Jan 12, 2024 - QIAGEN (QGEN) receives FDA clearance for the NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 versions of the integrated PCR-based clinical molecular testing system. 0

https://www.zacks.com/stock/news/2222219/qiagen-qgen-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2222219 Feb 06, 2024 - Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. 0

https://www.zacks.com/stock/news/2264566/here-s-what-key-metrics-tell-us-about-qiagen-qgen-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2264566 Apr 29, 2024 - While the top- and bottom-line numbers for Qiagen (QGEN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0